Breast cancer (BC) is a very heterogeneous disease characterized by different molecular and histopathological features; responses to treatment of its subtypes differ based on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status [83, 84]. Here, ESR1 is linked to breast cancer.